Company Offers Most Comprehensive, Cost-Effective Suite of Solutions to Detect and Screen for Methicillin Resistant Staphylococcus aureus (MRSA) “bioMérieux is committed to bringing innovative ...
bioMérieux, French manufacturer of diagnostic solutions, has received FDA 510(k) approval for NucliSENS EasyQ MRSA, an automated molecular test for MRSA, according to a company news release. The test ...
NucliSENS EasyQ® HPV, a molecular diagnostic test for the detection of human papillomavirus used in the prevention of cervical cancer. Cervical cancer is the leading cause of cancer-related deaths ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results